Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR

Delayed Quote. Delayed  - 06/27 09:59:59 pm
24.48 USD   -3.01%
06/13 ACORDA THERAPEU : Biotie Therapies Corp. Announces That the Delistin..
06/09 ACORDA THERAPEU : Pre-market Insights on Biotechnology Stocks -- Bio..
06/09 ACORDA THERAPEU : Presents Phase 1 Data on CVT-427 for Acute Treatme..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/21/2016 06/22/2016 06/23/2016 06/24/2016 06/27/2016 Date
25.08(c) 25.27(c) 26.31(c) 25.24(c) 24.49(c) Last
453 962 441 056 656 540 1 693 094 611 299 Volume
-0.91% +0.76% +4.12% -4.07% -2.97% Change
More quotes
Financials ($)
Sales 2016 515 M
EBIT 2016 5,30 M
Net income 2016 -6,42 M
Debt 2016 81,2 M
Yield 2016 -
Sales 2017 571 M
EBIT 2017 48,5 M
Net income 2017 -2,26 M
Debt 2017 97,1 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 2,41x
EV / Sales2017 2,21x
Capitalization 1 163 M
More Financials
Company
Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders.The company's two main products are Ampyra and Zanaflex Capsules.The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
06/27 ACORDA THERAPEUTICS : Completion of Acquisition or Disposition of Assets, Financ..
06/21 ACORDA THERAPEUTICS INC : Other Events (form 8-K)
06/16 ACORDA THERAPEUTICS : Presents Phase 1 Data on CVT-427 for Acute Treatment of Mi..
06/13 ACORDA THERAPEUTICS : Biotie Therapies Corp. Announces That the Delisting of Its..
06/10 ACORDA THERAPEUTICS INC : Submission of Matters to a Vote of Security Holders (f..
06/09 ACORDA THERAPEUTICS : to Present at the 37th Annual Goldman Sachs Global Healthc..
06/09 ACORDA THERAPEUTICS : Pre-market Insights on Biotechnology Stocks -- BioMarin Ph..
06/09 ACORDA THERAPEUTICS INC : Other Events, Financial Statements and Exhibits (form ..
06/09 ACORDA THERAPEUTICS : Presents Phase 1 Data on CVT-427 for Acute Treatment of Mi..
06/02 ACORDA THERAPEUTICS : to Discontinue Development of PLUMIAZ for Treatment of Epi..
More news
Sector news : Bio Therapeutic Drugs
06/27 MEDIVATION : Voted Top Workplace in San Francisco Bay Area for Fourth Year in a ..
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/23 BIOTECH FORUM DAILY DIGEST : Can Biotech Rally For The Second Week In A Row? New..
05/20 Acorda bags development of PLUMIAZ for epilepsy seizures after lagging Diasta..
05/15 Tracking Seth Klarman's Baupost Group Holdings - Q1 2016 Update
04/28 Acorda Therapeutics (ACOR) Q1 2016 Results - Earnings Call Webcast
04/28 Acorda Therapeutics misses by $0.01, beats on revenue
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends ACORDA THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions